Frontiers in Endocrinology (Jan 2022)

Commentary: Mortality Risk of Antidiabetic Agents for Type 2 Diabetes With COVID-19: A Systematic Review and Meta-Analysis

Li-Min Zhao,
Xie-Hui Chen,
Mei Qiu

Affiliations

Li-Min Zhao: Department of Geriatric Medicine, Shenzhen Longhua District Central Hospital, Shenzhen, China
Xie-Hui Chen: Department of Geriatric Medicine, Shenzhen Longhua District Central Hospital, Shenzhen, China
Mei Qiu: Department of General Medicine, Shenzhen Longhua District Central Hospital, Shenzhen, China

DOI: https://doi.org/10.3389/fendo.2021.825100
Journal volume & issue: Vol. 12

Abstract

No abstracts available.

Published in Frontiers in Endocrinology

ISSN: 1664-2392 (Online)
Publisher: Frontiers Media S.A.
Country of publisher: Switzerland
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the endocrine glands. Clinical endocrinology
Website: https://www.frontiersin.org/journals/endocrinology

About the journal